Leishmaniasis vaccination: Targeting the source of infection

Journal of Experimental Medicine

Volumn 194, Issue 3, 2001, Pages

  Reed, S G ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

DISEASE CARRIER; DISEASE TRANSMISSION; DRUG SCREENING; HUMAN; IMMUNE RESPONSE; LEISHMANIASIS; NONHUMAN; NOTE; PRIORITY JOURNAL; PSYCHODIDAE; VACCINATION;

EID: 0035817254     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.194.3.f7     Document Type: Note

References (18)

1. The regulation of immunity to Leishmania major
2. Toward a defined anti-Leishmania vaccine targeting vector antigens: Characterization of a protective salivary protein
3. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity
4. Variation in the salivary peptide, maxadilan, from species in the Lutzomyia longipalpis complex
5. Transforming growth factor-β in leishmanial infection: An important parasite escape mechanism
6. + lymphocytes in vivo during healing and progressive murine leishmaniasis
7. Interleukin 10 production correlates with pathology in human Leishmania donovani infections
8. T cell and cytokine responses in leishmaniasis
9. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis
10. IL-12 is required for natural killer cell activation and subsequent T helper cell development in experimental leishmaniasis
11. Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies
12. Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. III. Inhibition of leishmanial lesion in the guinea-pig by delayed hypersensitivity reaction to unrelated antigens
13. Histological studies of hypersensitive reaction. Part I. The contrast between the histological responses in the tuberculin (allergic)type and the anaphylactic type of skin reactions
14. Delayed hypersensitivity induced by antigen-antibody complexes
15. Cloning of a Mycobacterium tuberculosis gene encoding a PPD protein that elicits strong tuberculosis specific delayed type hypersensitivity
16. The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge
17. Vaccine requirements for sustained cellular immunity to an intracellular parasite infection
18. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran